Seres Therapeutics
AUDIT: Seres Therapeutics: The Honesty of Decay: Seres Therapeutics, the FMT Standardization Trap, and the Collapse of the Microbiome Factory
Seres Therapeutics' 99% collapse exposes the terminal CAPEX crisis of the FDA's LBP framework. Why industrializing the human microbiome is a costly trap.